[EN] SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS [FR] COMPOSÉS TRICYCLIQUES SUBSTITUÉS POSSÉDANT UNE ACTIVITÉ CONTRE LES RÉCEPTEURS EP1
[EN] SUBSTITUTED TRICYCLIC COMPOUNDS WITH ACTIVITY TOWARDS EP1 RECEPTORS [FR] COMPOSÉS TRICYCLIQUES SUBSTITUÉS POSSÉDANT UNE ACTIVITÉ CONTRE LES RÉCEPTEURS EP1
[EN] PYRROLOQUINOLINE AND PIPERIDOQUINOLINE DERIVATIVES, PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USES THEREOF<br/>[FR] DERIVES DE LA PYRROLOQUINOLINE ET DE LA PIPERIDOQUINOLINE, PREPARATION DE CES DERNIERS, COMPOSITIONS LES CONTENANT ET UTILISATIONS
申请人:ASTRAZENECA AB
公开号:WO2005075476A1
公开(公告)日:2005-08-18
Compounds of general formula (I) wherein n, R1, R2, R3, R4 and Ar are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
PYRROLOQUINOLINE AND PIPERIDOQUINOLINE DERIVATIVES, PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USES THEREOF
申请人:AstraZeneca AB
公开号:EP1716146A1
公开(公告)日:2006-11-02
Pyrroloquinoline and piperidoquinoline derivatives, preparation thereof, compositions containing them and uses thereof
申请人:Hu Yun-Jin
公开号:US20070161619A1
公开(公告)日:2007-07-12
Compounds of general formula:
wherein n, R
1
, R
2
, R
3
, R
4
and Ar are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.